BioLife Solutions (BLFS) Misses Q2 EPS by 2c ; Offers Guidance

BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $43.64 million.

GUIDANCE:

BioLife Solutions sees FY2023 revenue of $144-158 million, versus the consensus of $184.1 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
• Logistic Properties of the Americas (LPA) Reports Q2 results